查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094814

神經科病患監測市場－2026-2032年全球市場預測

Neurology Patient Monitoring Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經病學領域的病患監測市場將成長至 114.9 億美元，複合年成長率為 9.70%。

主要市場統計數據
基準年 2025 60億美元
預計年份：2026年 65億美元
預測年份 2032 114.9億美元
複合年成長率 (%) 9.70%

面對中風、癲癇、失智症、帕金森氏症、創傷性腦損傷、睡眠障礙和神經重症監護等疾病日益加重的臨床負擔，神經系統疾病病患監測正成為現代醫療體系神經照護的關鍵支柱。此領域涵蓋腦電圖（EEG）、顱內壓監測、腦氧飽和度測量、肌電圖（EMG）、神經生命徵象監測、穿戴式神經感測器、遠端患者監護平台以及協作式臨床決策支援工具。推動這一領域發展的需求源於對早期發現神經功能惡化、在加護病房（ICU）進行持續評估、改進癲癇發作監測、中風後康復隨訪以及慢性神經系統疾病長期監測的迫切需要。全球疾病負擔檢驗和公共衛生機構提供的經驗證的公共衛生證據一致表明，神經系統疾病是全球範圍內導致殘疾和健康壽命損失的主要原因。同時，隨著人口老化加劇和專業診斷手段的普及，對擴充性、可互通且臨床可靠的監測解決方案的需求日益成長。在此背景下，神經系統疾病患者的監測模式正從間歇性檢查轉向持續的、數據驅動的護理模式，該模式將醫院、復健中心、門診診所和居家照護機構連接起來。

神經監測領域的變革性變化

神經系統疾病患者監測領域正經歷著一場結構性變革，其驅動力來自數位醫療的普及、感測器的微型化、遠距神經病學的興起以及多模態生理數據的整合。傳統的監測流程嚴重依賴院內評估，而如今，攜帶式腦電圖（EEG）系統、無線神經監測設備、雲端數據審查以及支持症狀縱向追蹤的患者應用程式正日益成為其補充。醫院越來越重視神經重症監護中的即時監測，以檢測癲癇發作、腦缺氧、顱內壓升高和次發性腦損傷。同時，門診神經科也正在採用遠端監測來改善癲癇、運動障礙、偏頭痛、認知障礙和中風後復健等疾病的連續性治療。監管和臨床期望也在發生變化，更加關注網路安全、資料隱私、與電子健康記錄的互通性、臨床有效性以及對專科和非專科醫療團隊的易用性。這些變化促使醫療保健提供者優先考慮能夠提供可操作的神經學見解的監測系統，而不是孤立的資料流。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在透過加速解讀複雜的神經訊號和提高連續數據的臨床效用，變革神經病學領域的病患監測。 AI 驅動的分析技術正被廣泛應用於各種領域，包括透過腦電圖 (EEG) 檢測癲癇發作、輔助中風分診、睡眠分期、運動模式識別、認知功能評估以及在重症監護環境中早期發現神經功能惡化。機器學習模型可以處理來自腦電圖、影像相關工作流程、穿戴式裝置、語音生物標記、步態感測器和病患報告結局 (PRO) 的大量數據，幫助臨床醫生識別僅靠人工審核難以發現的模式。在神經科稀缺的情況下，這些協同作用尤其重要，因為自動化優先排序和決策支援工具能夠提高工作流程效率並及時向管理層報告。然而，AI 的實施需要透明的檢驗、減少偏差、確保臨床可解釋性、符合監管要求，並與臨床醫生主導的決策過程進行謹慎整合。 AI 不會取代神經病學專家；相反，它將增強我們持續監測患者、及早發現風險以及根據客觀神經學數據進行個性化隨訪的能力。

按地區分類的主要見解

在亞太地區，神經科病患監測的普及主要得益於大規模的病患群體、醫院的快速病患監測、不斷擴展的中風和癲癇診療路徑，以及都市區醫療系統對遠距遠端醫療基礎設施投入的增加。該地區，尤其是東亞地區，正面臨人口老化和中風及失智症患者數量居高不下的問題，這推動了對腦電圖（EEG）監測、中風後監測、遠端患者監護和穿戴式神經科設備的需求。在北美，由於成熟的重症監護網路、遠端監測保險報銷的推進、先進的臨床研究基礎設施以及電子健康記錄的高普及率，網路化神經科監測的普及應用十分活躍。臨床上對癲癇監測、神經重症監護、睡眠醫學和慢性神經系統疾病管理的重視，持續推動人工智慧驅動的神經科監測和遠端神經科工作流程的整合。在拉丁美洲，公共和私人投資正推動中風網路、癲癇診斷和遠端醫療的發展，但大都會圈和農村在醫療服務取得方面的差距仍然是推廣應用的主要挑戰。在歐洲，結構化的臨床指南、嚴格的資料保護要求、人口老化以及對高品質跨境神經系統疾病診療日益重視等因素，共同推動了對可互通且經臨床驗證的檢驗技術的需求。在中東，隨著專科醫院的建設、國家級數位健康策略的發展以及對中風、創傷性腦損傷和慢性神經系統疾病先進診療的投資，相關技術的應用正在加速推進。在非洲，儘管基礎設施和人力資源有限，但遠端神經病學、攜帶式診斷設備、行動通訊和低成本監測模式對於改善服務不足地區神經系統評估的可及性正變得日益重要。

主要群體分析

在東南亞國協，受數位化醫院計畫、遠端醫療日益普及以及中風、癲癇和神經退化性疾病被列為公共衛生重點的推動，神經系統疾病患者的監測正在不斷擴展。然而，具體實施情況因國家基礎設施和專家資源的不同而有所差異。在海灣合作理事會（GCC）的醫療保健系統中，先進的醫院功能、互聯互通的醫療服務和專業的神經科服務是優先事項，因此對重症監護、急診醫學、復健和慢性病管理中的綜合監測需求日益成長。歐盟以嚴格的法律規範、資料保護規則、互通性計劃和臨床品質標準為特徵，其證據生成、網路安全和失智症資料交換在神經系統監測的推廣中發揮核心作用。在金磚國家，人口大規模、三級醫療網路不斷擴展、國家數位化健康舉措以及對可擴展的神經系統診斷和隨訪工具日益成長的需求，整體。七國集團（G7）的特點是醫療數位化程度高、人口老化、研究生態系統健全，以及在神經系統疾病診療過程中廣泛應用人工智慧遠距監測工具。北約成員國中許多都擁有先進的急救、創傷和國防醫療系統，它們高度重視神經創傷、復健、重症監護響應和安全的醫療數據系統，這進一步強化了建構穩健的神經系統監測基礎設施的重要性。

主要國家的概況

美國擁有廣泛的專家網路和完善的數位醫療保險報銷機制，在遠距神經監測、神經重症監護技術、人工智慧診斷、門診腦電圖（EEG）工作流程以及遠距神經病學的臨床應用方面處於主導。加拿大強調公平取得醫療服務、遠距神經病學以及支持地域分散人群和偏遠社區醫療服務的監測模式。墨西哥正透過擴大私立醫院和增加遠端醫療的使用來加強其神經診斷基礎設施，而巴西則致力於推進卒中護理網路、癲癇醫療服務以及在主要都市區提供神經科專科服務。英國優先考慮綜合護理、向數位醫療轉型以及最佳化神經系統疾病治療路徑，而德國強大的醫院基礎設施和臨床工程基礎則支援先進腦電圖（EEG）、神經重症監護監測和復健技術的應用。法國持續投資於數位醫療和神經專科神經科服務，而俄羅斯的需求則主要來自中風、神經退化性疾病、創傷性腦損傷治療以及社區醫療現代化等方面的大規模需求。義大利和西班牙的特徵是人口老化、中風負擔沉重，以及對居家監測、遠距神經病學和復健支持日益成長的興趣。在中國，由於醫院現代化、國家數位醫療舉措以及對中風、癲癇、帕金森氏症和失智症治療需求的不斷成長，神經監測正在蓬勃發展。在印度，專科醫生短缺、先進診斷服務獲取不均以及神經系統疾病負擔沉重，都促使人們對價格合理的腦電圖（EEG）、遠程神經病學和遠程監測服務的需求日益成長。在日本，人口快速老化推動了對失智症、帕金森氏症、中風復健、睡眠障礙和長期神經監測的需求不斷增加。澳洲正透過遠端醫療醫療和互聯監測，擴大偏遠和農村地區神經科醫療服務的覆蓋範圍。同時，在韓國，先進的數位基礎設施、醫院對尖端技術的高採用率，以及將人工智慧和連網型設備積極融入臨床工作流程，都已證明是成功的。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的神經監測解決方案，這些方案應能應對諸如癲癇發作檢測、中風復健、顱內壓監測、神經重症監護中的病情進展、運動功能障礙追蹤、睡眠監測和認知衰退檢驗等高影響力應用情境。產品策略應著重於與電子健康記錄的互通性、安全的雲端架構、便於患者使用的穿戴式裝置設計，以及與神經科、重症監護醫生、護理師、復健團隊、睡眠專家和基層醫療提供者的工作流程整合。各機構應透過前瞻性臨床試驗、真實世界表現評估、部署後監測以及針對不同患者群體的可用性測試來累積證據，從而贏得臨床醫生的信任並獲得監管部門的批准。人工智慧驅動的工具應具備可解釋性、偏差評估、透明的效能報告和清晰的升級流程，以確保在臨床環境中安全部署。商業策略還應考慮報銷方案、專家資源、通訊基礎設施、語言要求、資料居住法規以及醫療服務模式的區域差異。與醫院、學術機構、遠端醫療網路、復健提供者和公共衛生計畫建立合作關係可以加快技術應用，但培訓和轉型管理工作對於將神經學數據轉化為及時的臨床行動仍然至關重要。

調查方法

本執行摘要是基於已驗證的二級資訊來源的系統性檢驗，這些資料包括公共衛生機構、同行評審的醫學文獻、臨床指南、監管出版刊物、醫院數位健康框架以及國際公認的疾病負擔資料集。調查方法強調對臨床、技術、監管和醫療服務指標進行三角驗證，以評估神經系統病患監測在區域、群體和重點國家的發展。分析排除了推測性的市場規模、市場佔有率和預測，而是專注於有證據支持的採納促進因素、疾病負擔、基礎設施建設、數位健康政策、臨床工作流程需求和技術檢驗要求。關鍵字和主題框架與神經病學、神經重症監護、遠端患者監護、腦電圖 (EEG) 監測、穿戴式神經設備、神經病學人工智慧、遠端神經病學、睡眠監測、復健監測和數位健康等領域的常用術語保持一致，從而確保臨床相關性並提高搜尋相關性。

結論

隨著醫療系統致力於更早發現疾病、改善慢性病管理以及提高專科工作流程的效率，神經科的病患監測正朝著更協作、持續和智慧主導的方向發展。遠端監測、攜帶式神經診斷、人工智慧分析、穿戴式神經感測器和可互通的數位健康平台的融合，正在拓展神經系統數據在醫院、診所、復健中心和居家照護機構的應用。區域應用程度將取決於基礎設施的成熟度、報銷系統、臨床有效性、人才引進、數據管治以及對臨床醫生主導的決策支援的信心。對於產業領導者而言，最大的商機在於提供臨床可靠、安全、易用且能夠將複雜的神經訊號轉化為可操作見解的解決方案。由於神經系統疾病持續對患者和醫療系統帶來沉重負擔，有效的監測技術將在改善及時干預、保障護理連續性和提升患者預後方面發揮核心作用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 神經病學病患監測市場：依產品類型分類

  • 腦電圖監測系統
  • 肌電監測系統
  • ICP監測系統
  • TCD設備

第8章：神經病學病患監測市場：依監護模式分類

  • 侵入性
  • 非侵入性

第9章：神經病學中的病患監測市場：連結性

  • 有線
  • 無線的

第10章：神經病學病患監測市場：依部署模式分類

  • 基於雲端的
  • 現場

第11章 神經病學病患監測市場：依應用領域分類

  • 癲癇監測
  • 神經退化性疾病的監測
  • 睡眠障礙監測
  • 中風監測

第12章 神經病學病患監測市場：依最終用戶分類

  • 門診部
  • 居家醫療
  • 醫院

第13章：神經科病患監測市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 神經病學病患監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 神經病學病患監測市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • ANT Neuro BV
  • BioSerenity Medical Devices Group
  • Bittium Corporation
  • Cadwell Industries, Inc.
  • Ceribell, Inc.
  • Compumedics Limited
  • DEYMED Diagnostic sro
  • Empatica Inc.
  • Epitel, Inc.
  • g.tec medical engineering GmbH
  • GE HealthCare Technologies Inc.
  • Hamamatsu Photonics KK
  • inomed Medizintechnik GmbH
  • Integra LifeSciences Holdings Corporation
  • Koninklijke Philips NV
  • Luciole Medical AG
  • Masimo Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroPace, Inc.
  • Neurosoft LLC
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • RAUMEDIC AG
  • Rimed Ltd.
  • Rune Labs, Inc.
  • Seer Medical Pty Ltd
  • Sophysa SA
  • UNEEG medical A/S
  • Viasonix Ltd.
  • Zeto, Inc.
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market is projected to grow by USD 11.49 billion at a CAGR of 9.70% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.00 billion
Estimated Year [2026] USD 6.50 billion
Forecast Year [2032] USD 11.49 billion
CAGR (%) 9.70%

Neurology patient monitoring is becoming a critical pillar of modern neurological care as healthcare systems respond to the rising clinical burden of stroke, epilepsy, dementia, Parkinson's disease, traumatic brain injury, sleep disorders, and neurocritical conditions. The field spans electroencephalography, intracranial pressure monitoring, cerebral oximetry, electromyography, neurovital monitoring, wearable neurological sensors, remote patient monitoring platforms, and connected clinical decision-support tools. Demand is being shaped by the need for earlier detection of neurological deterioration, continuous assessment in intensive care units, improved seizure surveillance, post-stroke rehabilitation tracking, and long-term monitoring of chronic neurological disorders. Verified public health evidence from global disease-burden studies and public health agencies consistently identifies neurological disorders as a leading cause of disability and lost healthy life years worldwide, while aging populations and expanding access to specialty diagnostics are increasing the need for scalable, interoperable, and clinically reliable monitoring solutions. In this environment, neurology patient monitoring is shifting from episodic testing toward continuous, data-driven care models that connect hospitals, rehabilitation centers, ambulatory clinics, and home-based care settings.

Transformative Shifts in the Neurology Monitoring Landscape

The neurology patient monitoring landscape is undergoing a structural transformation driven by digital health adoption, sensor miniaturization, tele-neurology, and the integration of multimodal physiological data. Traditional monitoring workflows that relied heavily on facility-based assessments are increasingly being complemented by portable EEG systems, wireless neuro-monitoring devices, cloud-enabled data review, and patient-facing applications that support longitudinal symptom tracking. Hospitals are placing greater emphasis on real-time monitoring in neurocritical care to detect seizures, cerebral hypoxia, intracranial hypertension, and secondary brain injury. At the same time, outpatient neurology is adopting remote monitoring to improve continuity of care for epilepsy, movement disorders, migraine, cognitive impairment, and post-stroke recovery. Regulatory and clinical expectations are also evolving, with stronger focus on cybersecurity, data privacy, interoperability with electronic health records, clinical validation, and usability for both specialists and non-specialist care teams. These shifts are encouraging healthcare providers to prioritize monitoring systems that deliver actionable neurological insights rather than isolated data streams.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is reshaping neurology patient monitoring by enabling faster interpretation of complex neurological signals and improving the clinical utility of continuous data. AI-enabled analytics are increasingly being explored for seizure detection in EEG, stroke triage support, sleep-stage classification, movement pattern recognition, cognitive assessment, and early identification of neurological deterioration in critical care environments. Machine learning models can process high-volume data from EEG, imaging-adjacent workflows, wearables, speech biomarkers, gait sensors, and patient-reported outcomes, helping clinicians identify patterns that may be difficult to detect through manual review alone. The cumulative impact is particularly relevant in settings facing neurologist shortages, where automated prioritization and decision-support tools can improve workflow efficiency and support timely escalation. However, adoption depends on transparent validation, bias mitigation, clinical explainability, regulatory compliance, and careful integration into clinician-led decision-making. AI is not replacing neurological expertise; it is expanding the capacity to monitor patients continuously, detect risk earlier, and personalize follow-up based on objective neurological data.

Key Regional Insights

In Asia-Pacific, neurology patient monitoring adoption is supported by large patient populations, rapid hospital digitization, expanding stroke and epilepsy care pathways, and growing investment in telehealth infrastructure across urban and regional health systems. The region's aging demographic profile, especially in East Asia, and the high absolute burden of stroke and dementia are increasing demand for EEG monitoring, post-stroke monitoring, remote patient monitoring, and wearable neurological devices. North America demonstrates strong uptake of connected neurological monitoring due to mature intensive care networks, reimbursement progress for remote monitoring, advanced clinical research infrastructure, and high adoption of electronic health records. Clinical emphasis on seizure surveillance, neurocritical care, sleep medicine, and chronic neurological disease management continues to support integration of AI-enabled neurology monitoring and tele-neurology workflows. Latin America is advancing through public and private investments in stroke networks, epilepsy diagnostics, and telemedicine, although access disparities between metropolitan and rural areas remain a key implementation challenge. Europe benefits from structured clinical guidelines, strong data protection requirements, aging demographics, and cross-border emphasis on quality neurological care, supporting demand for interoperable and clinically validated monitoring technologies. The Middle East is accelerating adoption through specialist hospital development, national digital health strategies, and investment in advanced care for stroke, traumatic brain injury, and chronic neurological disease. Africa faces infrastructure and workforce constraints, but tele-neurology, portable diagnostics, mobile connectivity, and lower-cost monitoring models are increasingly relevant for improving access to neurological assessment in underserved regions.

Key Group Insights

ASEAN countries are expanding neurology patient monitoring through digital hospital programs, wider telemedicine acceptance, and increasing recognition of stroke, epilepsy, and neurodegenerative disease as public health priorities, though implementation varies by national infrastructure and specialist availability. GCC health systems are prioritizing advanced hospital capabilities, connected care, and specialty neurology services, creating demand for integrated monitoring in intensive care, emergency medicine, rehabilitation, and chronic disease management. The European Union is shaped by strong regulatory oversight, data protection rules, interoperability initiatives, and clinical quality standards, making evidence generation, cybersecurity, and secure data exchange central to neurology monitoring deployment. BRICS economies present diverse but significant adoption drivers, supported by large populations, growing tertiary care networks, domestic digital health initiatives, and increasing need for scalable neurological diagnostics and follow-up tools across stroke, epilepsy, dementia, and traumatic brain injury care. G7 countries are characterized by advanced healthcare digitization, aging populations, strong research ecosystems, and broader use of AI-enabled and remote monitoring tools in neurology care pathways. NATO member countries, many of which operate advanced emergency, trauma, and defense medical systems, also emphasize neurotrauma, rehabilitation, critical care readiness, and secure health data systems, reinforcing the role of resilient neurology monitoring infrastructure.

Key Country Insights

The United States leads in clinical adoption of remote neurological monitoring, neurocritical care technologies, AI-enabled diagnostics, ambulatory EEG workflows, and tele-neurology, supported by extensive specialist networks and digital health reimbursement mechanisms. Canada emphasizes equitable access, tele-neurology, and monitoring models that support care delivery across geographically dispersed populations and remote communities. Mexico is strengthening neurological diagnostics through expanding private hospital capabilities and growing telehealth use, while Brazil is advancing stroke care networks, epilepsy services, and specialist neurology access in major urban centers. The United Kingdom prioritizes integrated care, digital health transformation, and neurological pathway optimization, while Germany's strong hospital infrastructure and clinical engineering base support adoption of advanced EEG, neurocritical monitoring, and rehabilitation technologies. France continues to invest in digital health and specialist neurology access, while Russia's demand is influenced by large-scale needs in stroke, neurodegenerative disease, traumatic brain injury care, and regional healthcare modernization. Italy and Spain are shaped by aging populations, stroke burden, and growing interest in home-based monitoring, tele-neurology, and rehabilitation support. China is scaling neurological monitoring through hospital modernization, domestic digital health initiatives, and growing demand for stroke, epilepsy, Parkinson's disease, and dementia care. India is seeing rising need for affordable EEG, tele-neurology, and remote monitoring due to specialist shortages, uneven access to advanced diagnostics, and a high burden of neurological conditions. Japan's super-aging population drives demand for dementia, Parkinson's disease, stroke recovery, sleep disorder, and long-term neurological monitoring. Australia is expanding remote and rural neurology access through telehealth-enabled care and connected monitoring, while South Korea benefits from advanced digital infrastructure, high hospital technology adoption, and active integration of AI and connected devices in clinical workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated neurology monitoring solutions that address high-impact use cases such as seizure detection, stroke recovery, intracranial pressure surveillance, neurocritical deterioration, movement disorder tracking, sleep monitoring, and cognitive decline assessment. Product strategies should focus on interoperability with electronic health records, secure cloud architecture, patient-friendly wearable design, and workflow integration for neurologists, intensivists, nurses, rehabilitation teams, sleep specialists, and primary care providers. Organizations should build evidence through prospective clinical studies, real-world performance evaluation, post-deployment surveillance, and usability testing across diverse patient populations to support clinician confidence and regulatory acceptance. AI-enabled tools should be developed with explainability, bias assessment, transparent performance reporting, and clear escalation protocols to ensure safe deployment in clinical environments. Commercial strategies should also account for regional differences in reimbursement, specialist availability, connectivity, language requirements, data residency rules, and care delivery models. Partnerships with hospitals, academic centers, telehealth networks, rehabilitation providers, and public health programs can accelerate adoption, while training and change-management initiatives remain essential for converting neurological data into timely clinical action.

Research Methodology

This executive summary is based on a structured review of verified secondary sources, including public health agencies, peer-reviewed medical literature, clinical guidelines, regulatory publications, hospital digital health frameworks, and internationally recognized disease-burden datasets. The methodology emphasizes triangulation across clinical, technological, regulatory, and healthcare delivery indicators to assess how neurology patient monitoring is evolving across regions, groups, and key countries. The analysis excludes speculative market sizing, market share, and forecasting, and instead focuses on evidence-backed adoption drivers, disease burden, infrastructure readiness, digital health policies, clinical workflow needs, and technology validation requirements. Keywords and thematic framing were aligned with current terminology used in neurology, neurocritical care, remote patient monitoring, EEG monitoring, wearable neurological devices, artificial intelligence in neurology, tele-neurology, sleep monitoring, rehabilitation monitoring, and digital health to support search relevance while maintaining clinical accuracy.

Conclusion

Neurology patient monitoring is entering a more connected, continuous, and intelligence-driven phase as healthcare systems seek earlier detection, improved chronic disease management, and more efficient specialist workflows. The convergence of remote monitoring, portable neurodiagnostics, AI analytics, wearable neurological sensors, and interoperable digital health platforms is expanding the role of neurological data across hospitals, clinics, rehabilitation centers, and home care environments. Regional adoption will depend on infrastructure maturity, reimbursement structures, clinical validation, workforce capacity, data governance, and trust in clinician-led decision support. For industry leaders, the strongest opportunities lie in solutions that are clinically credible, secure, easy to use, and capable of turning complex neurological signals into actionable insights. As neurological disorders continue to impose a substantial burden on patients and health systems, effective monitoring technologies will play a central role in improving timely intervention, care continuity, and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurology Patient Monitoring Market, by Product Type

  • 7.1. Introduction
  • 7.2. EEG Monitoring Systems
  • 7.3. EMG Monitoring Systems
  • 7.4. ICP Monitoring System
  • 7.5. TCD Device

8. Neurology Patient Monitoring Market, by Monitoring Mode

  • 8.1. Introduction
  • 8.2. Invasive
  • 8.3. Non Invasive

9. Neurology Patient Monitoring Market, by Connectivity

  • 9.1. Introduction
  • 9.2. Wired
  • 9.3. Wireless

10. Neurology Patient Monitoring Market, by Deployment Mode

  • 10.1. Introduction
  • 10.2. Cloud Based
  • 10.3. On Premise

11. Neurology Patient Monitoring Market, by Application

  • 11.1. Introduction
  • 11.2. Epilepsy Monitoring
  • 11.3. Neurodegenerative Disease Monitoring
  • 11.4. Sleep Disorder Monitoring
  • 11.5. Stroke Monitoring

12. Neurology Patient Monitoring Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Care Centers
  • 12.3. Home Care Settings
  • 12.4. Hospitals

13. Neurology Patient Monitoring Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Neurology Patient Monitoring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurology Patient Monitoring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. ANT Neuro B.V.
  • 17.2. BioSerenity Medical Devices Group
  • 17.3. Bittium Corporation
  • 17.4. Cadwell Industries, Inc.
  • 17.5. Ceribell, Inc.
  • 17.6. Compumedics Limited
  • 17.7. DEYMED Diagnostic s.r.o.
  • 17.8. Empatica Inc.
  • 17.9. Epitel, Inc.
  • 17.10. g.tec medical engineering GmbH
  • 17.11. GE HealthCare Technologies Inc.
  • 17.12. Hamamatsu Photonics K.K.
  • 17.13. inomed Medizintechnik GmbH
  • 17.14. Integra LifeSciences Holdings Corporation
  • 17.15. Koninklijke Philips N.V.
  • 17.16. Luciole Medical AG
  • 17.17. Masimo Corporation
  • 17.18. Medtronic plc
  • 17.19. Natus Medical Incorporated
  • 17.20. NeuroPace, Inc.
  • 17.21. Neurosoft LLC
  • 17.22. Nihon Kohden Corporation
  • 17.23. Nonin Medical, Inc.
  • 17.24. RAUMEDIC AG
  • 17.25. Rimed Ltd.
  • 17.26. Rune Labs, Inc.
  • 17.27. Seer Medical Pty Ltd
  • 17.28. Sophysa SA
  • 17.29. UNEEG medical A/S
  • 17.30. Viasonix Ltd.
  • 17.31. Zeto, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EEG MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EEG MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EEG MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMG MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EMG MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMG MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ICP MONITORING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ICP MONITORING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ICP MONITORING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TCD DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TCD DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TCD DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WIRED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WIRED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WIRED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WIRELESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WIRELESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WIRELESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EPILEPSY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EPILEPSY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EPILEPSY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEURODEGENERATIVE DISEASE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEURODEGENERATIVE DISEASE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEURODEGENERATIVE DISEASE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SLEEP DISORDER MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SLEEP DISORDER MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SLEEP DISORDER MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STROKE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STROKE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STROKE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 136. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 137. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 143. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 144. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. CANADA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MEXICO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. BRAZIL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED KINGDOM NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. GERMANY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. FRANCE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ITALY NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. AUSTRALIA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. SOUTH KOREA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 253. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025